Crinetics Pharmaceuticals
CRNX
#3122
Rank
A$6.09 B
Marketcap
$76.12
Share price
0.34%
Change (1 day)
74.44%
Change (1 year)

Earnings for Crinetics Pharmaceuticals (CRNX)

Earnings in 2024 (TTM): -A$0.4 B

According to Crinetics Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$0.39 B. In 2023 the company made an earning of -A$0.33 B a decrease over its 2022 earnings that were of -A$0.25 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Crinetics Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.4 B21.5%
2023 -A$0.33 B30.88%
2022 -A$0.25 B52.28%
2021 -A$0.17 B45.83%
2020 -A$0.12 B46.39%
2019 -A$75.63 M85.96%
2018 -A$40.67 M196.11%
2017 -A$13.74 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.19 B-51.61%๐Ÿ‡บ๐Ÿ‡ธ USA